Dental Non-Face-to-Face Treatment Participation Low and Unsatisfactory

English

简体中文 繁體中文 English Filipino हिन्दी Hmong Bahasa Indonesia 日本語 Basa Jawa 한국어 ພາສາລາວ Bahasa Melayu മലയാളം ဗမာစာ سنڌي தமிழ் ไทย Tiếng Việt Afrikaans Shqip العربية አማርኛ Հայերեն Azərbaycan dili Euskara Беларуская мова বাংলা Bosanski Български Català Cebuano Chichewa Corsu Italiano Hrvatski Čeština‎ Dansk Nederlands Esperanto Eesti Suomi Frysk Galego ქართული Ελληνικά ગુજરાતી Kreyol ayisyen Deutsch Français Harshen Hausa Ōlelo Hawaiʻi עִבְרִית Magyar Íslenska Igbo Gaeilge ಕನ್ನಡ Қазақ тілі ភាសាខ្មែរ كوردی‎ Кыргызча Latin Latviešu valoda Lietuvių kalba Lëtzebuergesch Македонски јазик Malagasy Maltese Te Reo Māori मराठी Монгол नेपाली Norsk bokmål پښتو فارسی Polski Português ਪੰਜਾਬੀ Română Русский Samoan Gàidhlig Српски језик Sesotho Shona සිංහල Slovenčina Slovenščina Afsoomaali Español Basa Sunda Kiswahili Svenska Тоҷикӣ తెలుగు Türkçe Українська اردو O‘zbekcha Cymraeg isiXhosa יידיש Yorùbá Zulu

South Korea: Since February 2020, non-face-to-face treatment has been temporarily allowed in South Korea. However, after three years, the results of a recent study by the Health Insurance Review and Assessment Service (HIRA) show that dental participation in non-face-to-face treatment was only 1%.

Dental Participation in Non-Face-to-Face Treatment

According to the study, from February 24, 2020 to February 23, 2021, only 181 out of 18,459 dental clinics participated in non-face-to-face treatment, less than 1% in proportion.

On the other hand, the non-face-to-face participation rate in medical sciences was 23.8%, approaching 1 out of 4 places. The total participation rate of oriental medicine based on the same standard was 8.6%.

Morbidity During Non-Face-to-Face Treatment

During the same period, there were significant health concerns among dental patients who received non-face-to-face treatment.

The most common issue was gingivitis and periodontal disease (42.9%) followed by dental facial abnormalities and malocclusion (17.7%), dental caries (9.8%), pulp and disease of apical tissues (4.3%), and buried and impacted teeth (3.2%). Dental oral medicine was prescribed to 2,830 people, accounting for 0.5% of all non-face-to-face treatment patients.

The research team stated that the policy showed an effect suitable for its main purpose in several related indicators under the COVID-19 situation. However, sustainable policy operation will be possible only when operational guidelines that can be improved are developed and applied.